Kennedy David 4

4 · GreenLight Biosciences Holdings, PBC · Filed Feb 4, 2022

Form 4

Period: 2022-02-02

General Counsel & Secretary

Transactions

Award
Stock Option (Right to Buy)
2022-02-02+235,992→ 235,992 total
Exercise: $1.23Exp: 2031-03-25→ Common Stock (235,992 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+3,693→ 3,693 total
Exercise: $1.23Exp: 2031-03-25→ Common Stock (3,693 underlying)
Award
Stock Option (Right to Buy)
2022-02-02+66,560→ 66,560 total
Exercise: $2.61Exp: 2031-06-30→ Common Stock (66,560 underlying)

Footnotes (4)

[F1]25% of the shares underlying the option vested or shall vest on July 17, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting August 17, 2021.
[F2]This option was issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
[F3]25% of the shares underlying the option vested on July 17, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting August 17, 2021.
[F4]25% of the shares underlying the option vested or shall vest on June 30, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting July 30, 2022.

Documents

1 file